Table 3 Validation of the extrapolated estimates by 13 years of follow-up and the Kaplan-Meier method
From: Estimating the lifelong health impact and financial burdens of different types of lung cancer
Cohort size | 13-year follow-up Kaplan-Meier estimate, mean (SE) months | Estimate using the extrapolation based on the first 7 years of follow-up, mean (SE) months | Relative bias,% | Pvalue* | |
|---|---|---|---|---|---|
SCLC | 4,425 | 14.75 (0.45) | 15.42 (0.38) | +4.54 | 0.424 |
NSCLC | 38,509 | 25.27 (0.24) | 25.89 (0.16) | +2.45 | 0.165 |
SqCC | 11,507 | 25.51 (0.43) | 26.21 (0.31) | +2.74 | 0.528 |
Adenocarcinoma | 20,926 | 27.05 (0.30) | 27.40 (0.23) | +1.29 | 0.551 |
Other NSCLCs | 6,076 | 18.68 (0.44) | 20.12 (0.37) | +7.71 | 0.122 |